Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novo Nordisk A/S (NYSE:NVO)

50.68
Delayed Data
As of Oct 19
 +0.55 / +1.10%
Today’s Change
30.89
Today|||52-Week Range
50.95
+41.33%
Year-to-Date

Today’s Trading

Previous close50.13
Today’s open50.80
Day’s range50.43 - 50.95
Volume2,632,155
Average volume (3 months)1,913,306
Market cap$98.6B
Dividend yield2.26%
Data as of 4:02pm ET, 10/19/2017

Growth & Valuation

Earnings growth (last year)+10.80%
Earnings growth (this year)--
Earnings growth (next 5 years)+5.50%
Revenue growth (last year)+3.81%
P/E ratio3.3
Price/Sales5.48
Price/Book19.55

Competitors

 Today’s
change
Today’s
% change
ABTAbbott Laboratories+0.23+0.41%
LLYEli Lilly and Co+0.63+0.73%
BMYBristol-Myers Squibb+0.97+1.52%
GSKGlaxoSmithKline+0.09+0.22%
Data as of 4:02pm ET, 10/19/2017

Financials

Next reporting dateNovember 1, 2017
EPS forecast (this quarter)$0.60
Annual revenue (last year)$16.6B
Annual profit (last year)$5.6B
Net profit margin33.93%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President &
Chief Executive Officer
Lars Fruergaard Jørgensen
Executive Vice President-
International Operations
Maziar Mike Doustdar
Corporate headquarters
Bagsværd, Capital Region

Forecasts